Speaker Information

 Tamsin Worrad
Tamsin Worrad Senior Regulatory Affairs Officer Teva Pharmaceuticals
Following her degree in Biochemistry and Genetics from The University of Nottingham, Tamsin took her first role in Regulatory Affairs within the Boots International department working on registering their range of cosmetics for markets outside of the EU. From there, she has worked within fragrance and flavour raw materials, colour cosmetics at Ciate and is now working in the OTC Medicine area, specifically on cosmetics and medical devices. Tamsin has extensive experience of the EU cosmetics market, as well as globally, and has a specific interest in borderline products and ‘grey areas’.


Pre-Conference Day

10:00 AM Getting Product Labelling Right: Incorporating Claims Compliance, Safety Assessments and Effective Artwork to Create Innovative Marketing whist Staying Compliant


Questions like: 
  • What information is actually expected on product labels in the EU?
  • How much evidence do we need to substantiate our claims?
  • Where do we encompass safety assessments and remain cost-effective?
Expect to be a part of intellectual discussion:
  • Using hands-on projects to understand the legislation behind EU labelling for cost effective compliance
  • Look at practical examples to clarify the proof and evidence required to substantiate claims in the EU
  • Gain a clear picture of how to incorporate safety assessments in to  labelling procedures  through focussed discussion

Conference Day One

3:30 PM Avoid Health Authority Inspection by Differentiating between OTC Drugs and Cosmetics to comply to EU Standards and a glance at US Borderline Cosmetics

  • Highlighting the legislative differences between over the counter drugs and cosmetics to prevent scrutiny from health authorities 
  • Exploring the grey area: how do you deal with the intersecting area of drugs and cosmetics? 
  • Preparing your case in line with health authority regulations should your product come under investigation
  • Cosmetics vs medical devices: touching on ambiguous legislation
  • A glance at the latest changes in US legislation and the impact this has on borderline cosmetics